QTRX Quanterix Corporation Stock Quote

QTRX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.17	Insider Own	7.20%	Shs Outstand	30.14M	Perf Week	-1.60%
Market Cap	2.66B	Forward P/E	-	EPS next Y	-1.09	Insider Trans	-5.56%	Shs Float	26.49M	Perf Month	19.09%
Income	-32.70M	PEG	-	EPS next Q	-0.33	Inst Own	75.80%	Short Float	1.88%	Perf Quarter	77.08%
Sales	76.20M	P/S	34.89	EPS this Y	-13.40%	Inst Trans	-1.04%	Short Ratio	1.24	Perf Half Y	118.54%
Book/sh	6.94	P/B	11.11	EPS next Y	5.20%	ROA	-17.00%	Target Price	72.00	Perf Year	226.14%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-23.00%	52W Range	10.90 - 92.57	Perf YTD	65.81%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-30.40%	52W High	-16.71%	Beta	-
Dividend %	-	Quick Ratio	7.20	Sales past 5Y	-	Gross Margin	52.50%	52W Low	607.66%	ATR	7.03
Employees	248	Current Ratio	7.70	Sales Q/Q	110.70%	Oper. Margin	-43.60%	RSI (14)	51.08	Volatility	8.14% 8.84%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	118.90%	Profit Margin	-42.90%	Rel Volume	1.01	Prev Close	82.66
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Mar 02 AMC	Payout	-	Avg Volume	401.77K	Price	77.10
Recom	-	SMA20	-3.48%	SMA50	16.36%	SMA200	80.79%	Volume	406,520	Change	-6.73%

Mar-02-21 05:25PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.73%
04:03PM	Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020 Business Wire
Mar-01-21 10:05AM	Preview: Quanterix's Earnings Benzinga +9.12%
Feb-25-21 06:05PM	Quanterix Kevin Hrusovsky to Present at the Cowen 41st Annual Health Care Conference on March 3 and Appear on the Feb. 26 Episode of the Health Care Rounds Podcast Business Wire -5.62%
Feb-23-21 11:19AM	Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021 Business Wire
Feb-18-21 11:59AM	Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference Business Wire
Feb-12-21 02:08PM	Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec Business Wire +7.20%
Feb-09-21 08:41AM	Did Business Growth Power Quanterix's (NASDAQ:QTRX) Share Price Gain of 287%? Simply Wall St.
Feb-08-21 03:12PM	Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Feb-04-21 07:00AM	Quanterix Prices Public Offering of Common Stock Business Wire +9.67%
Feb-03-21 04:25PM	Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock Business Wire
Jan-22-21 03:39PM	Quanterix to Participate in PMWC 2021 COVID-19 Conference Business Wire
Jan-13-21 08:30AM	Quanterix Provides Operational and Preliminary Financial Highlights Business Wire +13.81%
Jan-12-21 03:27AM	Quanterixs Covid-19 Antigen Test Cleared For Emergency Use In US; Shares Pop 10% SmarterAnalyst +12.75%
Jan-11-21 06:03PM	Quanterix stock jumps nearly 10% after company gets EUA for COVID-19 test MarketWatch +8.43%
04:30PM	Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test Business Wire
Jan-06-21 04:06PM	Quanterix Corporation to Present At 39th Annual J.P. Morgan Healthcare Conference Business Wire +5.19%
Dec-28-20 06:46PM	Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test Business Wire
Dec-10-20 12:02PM	Is QTRX A Good Stock To Buy Now? Insider Monkey +6.10%
Dec-09-20 09:00AM	Quanterix to Participate in Contagion Conference Business Wire
Nov-18-20 04:28PM	Quanterix Appoints William Geist as Chief Operating Officer Business Wire
Nov-13-20 12:36PM	Quanterix to Participate in the Canaccord Medical Technologies and Diagnostics Forum Business Wire
Nov-09-20 07:29AM	Quanterix Corporation Beat Analyst Profit Forecasts, And Analysts Have New Estimates Simply Wall St. -13.76%
Nov-05-20 04:16PM	Quanterix Corporation Releases Operating Results for Third Quarter 2020 Business Wire
Oct-30-20 05:32PM	908 Devices Names Kevin Hrusovsky, 30-year Biotechnology Veteran and Founder of Powering Precision Health, as Chairman of its Board of Directors PR Newswire
Oct-29-20 02:40PM	Quanterix Corporation to Release Third Quarter 2020 Financial Results on November 5, 2020 Business Wire
Oct-28-20 11:37AM	Kevin Hrusovsky to Speak at Precision Medicine Leaders Summits Precision Oncology Conference Business Wire
Oct-07-20 04:27PM	Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday TheStreet.com +17.56%
Oct-06-20 03:32PM	Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19) Business Wire
Oct-05-20 04:01PM	Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics Business Wire
Sep-10-20 09:00AM	Quanterix Simoa Technology Supports 42 Scientific Presentations at MSVirtual2020 Business Wire
Aug-25-20 12:28PM	What Is The Ownership Structure Like For Quanterix Corporation (NASDAQ:QTRX)? Simply Wall St.
Aug-11-20 04:34PM	Quanterix Announces Closing of Public Offering Including Exercise in Full of Underwriters Option to Purchase Additional Shares Business Wire
09:00AM	Quanterix to Participate in the Canaccord Genuity 40th Annual Growth Conference Business Wire
Aug-06-20 10:12PM	Quanterix Prices Public Offering of Common Stock Business Wire
04:11PM	Quanterix Announces Proposed Public Offering of Common Stock Business Wire
Aug-04-20 04:29PM	Quanterix Corporation Releases Operating Results for Second Quarter 2020 Business Wire
Aug-03-20 09:08AM	Quanterix Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020 Business Wire
Jul-29-20 09:30AM	Quanterix sNfL Assay and Simoa Technology First to Measure Neuronal Injury in COVID-19 Patients Blood Business Wire +12.54%
Jul-27-20 07:00AM	Quanterix to Participate in Alzheimers Association International Conference (AAIC) 2020 Business Wire
Jul-20-20 10:41AM	Quanterix Simoa Technology Powers New Insights into COVID-19 Immune Response and Reveals Indicators of Disease Severity Business Wire
Jul-05-20 10:02PM	Is Quanterix Corporation (QTRX) A Good Stock To Buy? Insider Monkey
Jun-26-20 09:37AM	Quanterix Corporation CEO to Present at MassBio: Possible Talk Series Business Wire
Jun-11-20 04:10PM	Quanterix to Host Virtual Annual Meeting of Stockholders Business Wire -6.24%
May-29-20 12:37PM	Quanterix Expands Menu of Ultra-Sensitive Neurology Assays with Simoa® P-Tau181 V2 Kit for Improved Detection and Study of Alzheimers Disease Business Wire
May-13-20 09:45AM	Quanterix Simoa Technology Sets New Standard in Protein Detection Business Wire
May-11-20 09:14AM	Quanterix Corporation (NASDAQ:QTRX) Just Reported And Analysts Have Been Cutting Their Estimates Simply Wall St.
08:26AM	Researchers Develop Breakthrough COVID-19 Antibody Test with 1,000-Fold Sensitivity Improvement Using Quanterix Simoa Technology Business Wire
May-06-20 10:02AM	Quanterix Corporation (QTRX) Q1 2020 Earnings Call Transcript Motley Fool +7.66%
May-05-20 04:05PM	Quanterix Corporation Releases Operating Results for First Quarter 2020 Business Wire
May-01-20 11:00AM	Quanterix CEO and Powering Precision Health Founder Kevin Hrusovsky to Appear on Passionate Pioneers Podcast Business Wire
Apr-28-20 02:45PM	Quanterix to Release First Quarter 2020 Financial Results and Host Conference Call on May 5, 2020 Business Wire
Apr-24-20 06:04PM	Quanterix Announces Simoa® Success Grant Program to Accelerate Promising Infectious Disease & Immunology Research Business Wire +7.09%
Apr-14-20 10:05AM	How Quanterix (QTRX) Stock Stands Out in a Strong Industry Zacks +8.21%
Apr-10-20 04:00PM	Quanterix Ultra-Sensitive Simoa Technology Demonstrates Promise for COVID-19 Acute Care, Immune Response Monitoring and Treatment Business Wire
Apr-09-20 01:15PM	Quanterix Corporation to Participate in the 19th Annual Needham Virtual Healthcare Conference Business Wire -8.11%
Mar-27-20 09:45AM	Quanterix Statement on COVID-19 Preparedness, Resiliency Efforts and Business Continuity Business Wire
Mar-11-20 08:13AM	Quanterix Corporation Annual Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St. -6.52%
Mar-09-20 04:05PM	Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2019 Business Wire -9.30%
Feb-21-20 04:32PM	Quanterix Corporation to Release Fourth Quarter 2019 Financial Results on March 9, 2020 and Present at Multiple Upcoming Healthcare Conferences Business Wire
Feb-11-20 11:44AM	Quanterix (NASDAQ:QTRX) Is Using Debt Safely Simply Wall St.
Jan-31-20 10:04AM	Quanterix Simoa Technology Advances the Field Toward a Sports-Related Concussion Blood Test Business Wire
Jan-10-20 02:03PM	Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-19-19 04:23PM	Hedge Funds Have Never Been This Bullish On Quanterix Corporation (QTRX) Insider Monkey
Dec-11-19 10:27AM	Does The Quanterix Corporation (NASDAQ:QTRX) Share Price Fall With The Market? Simply Wall St.
Nov-06-19 04:01PM	Quanterix Corporation Releases Operating Results for Third Quarter 2019 Business Wire -5.07%
Nov-04-19 04:00PM	Siemens Healthineers Enters into License and Supply Arrangement with Quanterix for Access to Neurofilament Light (Nf-L) Antibodies to Develop Nf-L Assays Business Wire
Nov-01-19 09:41AM	Hedge Funds Have Never Been More Bullish On Quanterix Corporation (QTRX) Insider Monkey
Oct-25-19 09:13AM	Quanterix Simoa Technology Unlocks Low-Level Markers Critical to Rapid Triage Test in Study for Active Pulmonary Tuberculosis Business Wire
Oct-22-19 04:30PM	Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019 Business Wire
Oct-18-19 11:13AM	3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Oct-03-19 09:00AM	Quanterix Announces Recipients of Annual Accelerator Grant Program Business Wire +11.06%
Oct-01-19 09:46AM	Need To Know: Quanterix Corporation (NASDAQ:QTRX) Insiders Have Been Selling Shares Simply Wall St.
Sep-26-19 07:00AM	Sherlock Bio gets DoD grant to bring CRISPR to the battlefield American City Business Journals
Sep-24-19 01:14PM	Powering Precision Health Announces 2019 Summit Business Wire -5.86%
Sep-16-19 06:21PM	Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019 Business Wire
Sep-11-19 08:00AM	Quanterix Simoa Technology Powers Multiple Sclerosis Research with More Than 50 Presentations at ECTRIMS 2019 Business Wire +7.48%
Aug-13-19 04:21PM	Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Aug-09-19 07:45AM	Quanterix Prices Public Offering of Common Stock Business Wire
Aug-07-19 04:23PM	Quanterix Announces Proposed Public Offering of Common Stock Business Wire
08:25AM	Quanterix Corporation (QTRX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:30AM	Quanterix Corporation Releases Operating Results for Second Quarter 2019 Business Wire
Jul-31-19 09:00AM	Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference Business Wire
Jul-30-19 10:30AM	Quanterix to Release Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6, 2019 Business Wire
Jul-26-19 11:16AM	Sarah Hlavinka Elected to Quanterix Board of Directors Business Wire
Jul-11-19 01:30PM	Quanterix to Convene Leading Industry Researchers at Alzheimers Association International Conference 2019 Following Closing of UmanDiagnostics Acquisition Business Wire
Jun-28-19 12:15PM	Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England Business Wire
Jun-27-19 10:43AM	Mass. diagnostics firms sign M&A deals worth $500M American City Business Journals +8.95%
Jun-26-19 04:00PM	Quanterix Announces Agreement to Acquire UmanDiagnostics, Worlds Leading Neurofilament Light (Nf-L) Antibody Supplier Business Wire
Jun-06-19 07:03AM	Did Quanterix's (NASDAQ:QTRX) Share Price Deserve to Gain 66%? Simply Wall St.
Jun-04-19 04:00PM	Quanterix Raises $49.7 Million and Announces Introduction of Latest Model Simoa HD-X Analyzer at BIO 2019 International Convention Business Wire
May-29-19 04:00PM	Quanterix Expands Headquarters to New, State-of-the-Art Facility in Billerica, Mass. as Demand Continues to Grow for its Disruptive Simoa Platforms Business Wire
May-16-19 10:30AM	Quanterix Announces $50,000 in Grants to Support Promising Oncology Research Business Wire
May-11-19 01:27PM	Heres What Hedge Funds Think About Quanterix Corporation (QTRX) Insider Monkey
May-10-19 11:23AM	Quanterix Corporation (QTRX) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 04:00PM	Quanterix Corporation Releases Operating Results for First Quarter 2019 Business Wire
May-06-19 11:30AM	Quanterix Simoa Technology Powers More Than 85 Percent of Neurofilament Light Biomarker Research to be Unveiled at American Academy of Neurology Annual Meeting Business Wire
May-02-19 04:00PM	Quanterix to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019 Business Wire
Apr-01-19 07:14AM	Will Quanterix Corporation's (NASDAQ:QTRX) Earnings Grow In The Next Couple Of Years? Simply Wall St. -9.41%
Mar-28-19 04:00PM	Quanterix Appoints Amol Chaubal as Chief Financial Officer Business Wire

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HRUSOVSKY E KEVIN	Chairman, President & CEO	Feb 19	Sale	90.34	3,493	315,562	1,002,443	Feb 22 04:34 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Feb 19	Sale	90.33	670	60,523	24,435	Feb 23 04:43 PM
Chaubal Amol	Chief Financial Officer	Feb 19	Sale	90.33	733	66,212	30,423	Feb 23 04:45 PM
Mattoon Dawn	Sr. VP, Research Products	Feb 19	Sale	90.33	871	78,680	33,642	Feb 23 04:36 PM
Fry John J	General Counsel & Secretary	Feb 19	Sale	90.33	871	78,680	34,530	Feb 23 04:39 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Feb 18	Sale	83.65	5,000	418,229	1,005,936	Feb 22 04:34 PM
Duffy David C.	SVP R&D and CTO	Feb 11	Sale	79.62	1,667	132,727	39,952	Feb 12 04:00 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Feb 09	Sale	78.18	5,000	390,887	1,010,936	Feb 10 04:11 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Feb 01	Sale	68.26	105	7,167	21,732	Feb 02 07:56 PM
Fry John J	General Counsel & Secretary	Feb 01	Sale	68.26	163	11,126	31,722	Feb 02 08:02 PM
Chaubal Amol	Chief Financial Officer	Feb 01	Sale	68.26	133	9,078	25,367	Feb 02 08:04 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Feb 01	Sale	66.77	8,249	550,788	997,539	Feb 02 08:12 PM
Mattoon Dawn	Sr. VP, Research Products	Feb 01	Sale	68.26	182	12,423	30,834	Feb 02 09:13 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jan 25	Sale	77.81	5,000	389,056	1,005,788	Jan 25 04:01 PM
Duffy David C.	SVP R&D and CTO	Jan 22	Sale	79.29	1,667	132,176	39,473	Jan 22 06:47 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jan 19	Sale	74.53	5,000	372,646	1,010,788	Jan 21 07:55 PM
DEKKERS MARIJN E	Director	Jan 11	Option Exercise	11.10	44,962	498,978	54,042	Jan 13 05:01 PM
DEKKERS MARIJN E	Director	Jan 11	Sale	48.65	44,962	2,187,514	9,080	Jan 13 05:01 PM
Mattoon Dawn	Sr. VP, Research Products	Jan 05	Sale	44.13	170	7,502	31,016	Jan 06 04:21 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Jan 05	Sale	44.13	98	4,325	21,837	Jan 06 04:21 PM
Fry John J	General Counsel & Secretary	Jan 05	Sale	44.13	153	6,752	31,885	Jan 06 04:21 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jan 05	Sale	44.13	3,510	154,902	1,015,788	Jan 06 04:21 PM
Chaubal Amol	Chief Financial Officer	Jan 05	Sale	44.13	124	5,472	25,500	Jan 06 04:23 PM
Duffy David C.	SVP R&D and CTO	Dec 18	Option Exercise	2.28	1,630	3,716	42,807	Dec 21 05:03 PM
Duffy David C.	SVP R&D and CTO	Dec 18	Sale	43.82	1,667	73,048	41,140	Dec 21 05:03 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Dec 08	Sale	46.98	2,000	93,960	1,019,298	Dec 10 05:48 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Dec 01	Sale	43.75	91	3,981	21,935	Dec 03 04:41 PM
Mattoon Dawn	Sr. VP, Research Products	Dec 01	Sale	43.75	158	6,912	31,186	Dec 03 04:40 PM
Chaubal Amol	Chief Financial Officer	Dec 01	Sale	43.75	115	5,031	25,624	Dec 03 04:40 PM
Fry John J	General Counsel & Secretary	Dec 01	Sale	43.75	141	6,168	32,038	Dec 03 04:40 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Dec 01	Sale	43.75	3,236	141,569	1,021,298	Dec 03 04:40 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Nov 19	Sale	44.25	2,000	88,500	1,024,534	Nov 20 04:19 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Nov 12	Sale	49.39	2,000	98,780	1,026,534	Nov 16 04:51 PM
Duffy David C.	SVP R&D and CTO	Nov 12	Sale	49.39	1,667	82,333	41,177	Nov 16 04:51 PM
Madaus Martin D	Director	Nov 05	Option Exercise	2.28	1,372	3,128	13,088	Nov 06 04:01 PM
Madaus Martin D	Director	Nov 05	Sale	42.45	1,372	58,241	11,716	Nov 06 04:01 PM
Madaus Martin D	Director	Nov 04	Option Exercise	2.28	1,600	3,648	13,316	Nov 06 04:01 PM
Madaus Martin D	Director	Nov 04	Sale	39.40	1,600	63,040	11,716	Nov 06 04:01 PM
Chaubal Amol	Chief Financial Officer	Nov 02	Sale	36.97	116	4,288	25,261	Nov 03 04:04 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Nov 02	Sale	36.97	3,264	120,666	1,028,534	Nov 03 04:05 PM
Fry John J	General Counsel & Secretary	Nov 02	Sale	36.97	142	5,250	31,085	Nov 03 04:04 PM
Mattoon Dawn	Sr. VP, Research Products	Nov 02	Sale	36.97	159	5,878	31,344	Nov 03 04:09 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Nov 02	Sale	36.97	91	3,364	21,188	Nov 03 04:13 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Oct 29	Sale	38.30	2,000	76,600	1,031,798	Nov 03 04:05 PM
Madaus Martin D	Director	Oct 20	Option Exercise	2.28	1,600	3,648	13,316	Oct 20 04:24 PM
Madaus Martin D	Director	Oct 20	Sale	42.57	1,600	68,112	11,716	Oct 20 04:24 PM
Madaus Martin D	Director	Oct 19	Option Exercise	2.28	1,600	3,648	13,316	Oct 20 04:24 PM
Madaus Martin D	Director	Oct 19	Sale	44.59	1,600	71,344	11,716	Oct 20 04:24 PM
Duffy David C.	SVP R&D and CTO	Oct 16	Sale	43.04	1,667	71,748	42,844	Oct 20 04:15 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Oct 13	Sale	44.49	2,000	88,980	1,033,798	Oct 15 05:36 PM
Madaus Martin D	Director	Oct 07	Option Exercise	2.28	1,600	3,648	13,316	Oct 08 05:43 PM
Madaus Martin D	Director	Oct 07	Sale	37.17	1,600	59,472	11,716	Oct 08 05:43 PM
Madaus Martin D	Director	Oct 06	Option Exercise	2.28	1,600	3,648	13,316	Oct 08 05:43 PM
Madaus Martin D	Director	Oct 06	Sale	36.47	1,600	58,357	11,716	Oct 08 05:43 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Oct 05	Sale	33.90	2,000	67,800	1,035,798	Oct 05 05:29 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Oct 01	Sale	34.12	92	3,139	21,279	Oct 02 04:00 PM
Chaubal Amol	Chief Financial Officer	Oct 01	Sale	34.12	116	3,958	25,377	Oct 02 04:00 PM
Mattoon Dawn	Sr. VP, Research Products	Oct 01	Sale	34.12	159	5,425	31,503	Oct 02 04:00 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Oct 01	Sale	34.12	3,286	112,126	1,037,798	Oct 02 04:00 PM
Fry John J	General Counsel & Secretary	Oct 01	Sale	34.12	143	4,880	31,227	Oct 02 04:00 PM
Madaus Martin D	Director	Sep 29	Option Exercise	1.96	1,600	3,138	12,654	Sep 30 04:10 PM
Madaus Martin D	Director	Sep 29	Sale	32.52	1,600	52,025	11,196	Sep 30 04:10 PM
Madaus Martin D	Director	Sep 28	Option Exercise	1.93	1,600	3,088	12,796	Sep 30 04:10 PM
Madaus Martin D	Director	Sep 28	Sale	33.09	1,600	52,944	11,196	Sep 30 04:10 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Sep 24	Sale	32.26	2,000	64,520	1,041,084	Sep 29 04:53 PM
Madaus Martin D	Director	Sep 17	Option Exercise	1.93	1,600	3,088	12,796	Sep 17 05:49 PM
Duffy David C.	SVP R&D and CTO	Sep 17	Sale	32.43	1,667	54,061	44,511	Sep 17 05:47 PM
Madaus Martin D	Director	Sep 17	Sale	32.43	1,600	51,888	11,196	Sep 17 05:49 PM
Madaus Martin D	Director	Sep 16	Option Exercise	1.93	1,600	3,088	12,796	Sep 17 05:49 PM
Madaus Martin D	Director	Sep 16	Sale	33.16	1,600	53,056	11,196	Sep 17 05:49 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Sep 15	Sale	33.15	3,500	116,037	1,043,084	Sep 16 04:08 PM
Madaus Martin D	Director	Sep 02	Option Exercise	1.93	1,600	3,088	12,796	Sep 03 07:44 PM
Madaus Martin D	Director	Sep 02	Sale	35.08	1,600	56,128	11,196	Sep 03 07:44 PM
Madaus Martin D	Director	Sep 01	Option Exercise	1.93	1,600	3,088	12,796	Sep 03 07:44 PM
Madaus Martin D	Director	Sep 01	Sale	35.37	1,600	56,592	11,196	Sep 03 07:44 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Sep 01	Sale	34.91	3,390	118,349	1,046,584	Sep 03 07:48 PM
Mattoon Dawn	Sr. VP, Research Products	Sep 01	Sale	34.91	165	5,760	31,662	Sep 03 07:50 PM
Fry John J	General Counsel & Secretary	Sep 01	Sale	34.91	148	5,167	31,370	Sep 03 07:52 PM
Chaubal Amol	Chief Financial Officer	Sep 01	Sale	34.91	120	4,189	25,493	Sep 03 07:54 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Sep 01	Sale	34.91	95	3,317	21,371	Sep 03 07:56 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 25	Sale	35.28	3,500	123,468	1,049,974	Aug 26 05:09 PM
Madaus Martin D	Director	Aug 19	Option Exercise	1.93	1,600	3,088	12,796	Aug 20 04:32 PM
Duffy David C.	SVP R&D and CTO	Aug 19	Sale	34.92	1,680	58,666	46,178	Aug 20 04:32 PM
Madaus Martin D	Director	Aug 19	Sale	34.92	1,600	55,872	11,196	Aug 20 04:32 PM
Madaus Martin D	Director	Aug 18	Option Exercise	1.93	1,600	3,088	12,796	Aug 20 04:32 PM
Madaus Martin D	Director	Aug 18	Sale	34.52	1,600	55,232	11,196	Aug 20 04:32 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 14	Sale	36.72	3,500	128,533	1,053,474	Aug 14 05:40 PM
DEKKERS MARIJN E	Director	Aug 07	Sale	32.49	27,619	897,341	0	Aug 11 04:52 PM
Madaus Martin D	Director	Aug 05	Option Exercise	1.93	3,200	6,176	14,396	Aug 05 05:49 PM
Madaus Martin D	Director	Aug 05	Sale	32.89	3,200	105,248	11,196	Aug 05 05:49 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 04	Sale	32.11	4,000	128,437	1,056,974	Aug 05 05:14 PM
Chaubal Amol	Chief Financial Officer	Aug 03	Sale	32.26	114	3,677	25,613	Aug 05 05:21 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 03	Sale	32.26	3,230	104,188	1,060,974	Aug 05 05:14 PM
Fry John J	General Counsel & Secretary	Aug 03	Sale	32.25	141	4,548	31,518	Aug 05 05:10 PM
Roskey Mark T.	SVP, Commercial & Accelerator	Aug 03	Sale	32.25	90	2,903	21,466	Aug 05 05:51 PM
Mattoon Dawn	Sr. VP, Research Products	Aug 03	Sale	32.26	156	5,032	31,827	Aug 05 05:53 PM
Madaus Martin D	Director	Jul 21	Option Exercise	1.93	1,600	3,088	12,796	Jul 22 07:13 PM
Madaus Martin D	Director	Jul 21	Sale	31.45	1,600	50,320	11,196	Jul 22 07:13 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jul 21	Sale	31.87	2,636	84,016	1,064,204	Jul 23 08:38 PM
Madaus Martin D	Director	Jul 20	Option Exercise	1.93	1,600	3,088	12,796	Jul 22 07:13 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience